VA San Diego Healthcare System
San Diego, California, 92093, United States
NCT Number: NCT01517672
Identifying neural mechanisms of posttraumatic stress disorder (PTSD) treatment could help elucidate reasons for variable treatment response and identify novel treatment targets. Exposure-based therapies have been associated with decreased amygdala and increased cingulate cortex response during emotional processing. The current study examined whether cognitive therapy for PTSD in women reduces activation in insula and amygdala and enhances activation in prefrontal regions during emotional anticipation and pre-treatment prefrontal activation predicts treatment response.
Looking for future studies?
Notify Me18 year–60 year
Female
Interventional
Not applicable
San Diego, California, 92093, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
10 individual sessions of this form of cognitive therapy, with a trained therapist.
Time frame: After 10 sessions of cognitive behavioral therapy (CBT) (10-14 weeks)
The CAPS is a widely used measure of PTSD severity. Intent was to administer 10 sessions of CBT over a period of 10-14 weeks. Primary outcome was CAPS at the end of CBT administration.
Time frame: 3 months post-treatment
University of California, San Diego
Other
Neurobiology of Severe Psychological Trauma in Women
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05862467
Autism, Autism Spectrum Disorder
Laramie, Wyoming, United States
View Trial DetailsNCT06130501
Chemically-Induced Disorders, Mental Disorders
Cape Girardeau, Missouri, United States
View Trial DetailsNCT05280691
Anxiety Disorders, Behavior
Winterthur, Canton of Zurich, Switzerland
View Trial DetailsNCT07108608
Chemically-Induced Disorders, Mental Disorders
Baltimore, Maryland, United States
View Trial Details